Cargando…
Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?
BACKGROUND: The coronavirus disease 2019 (COVID-19), an acute respiratory disease caused by a novel coronavirus (SARS-CoV-2), is emerging as a worldwide public health emergency. Several scientific contributions reported the potential relevance of human leukocyte antigen (HLA) polymorphism and suscep...
Autores principales: | Greco, N., Meacci, A., Mora, B., Vestri, A., Picarelli, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856018/ https://www.ncbi.nlm.nih.gov/pubmed/35175152 http://dx.doi.org/10.1080/07853890.2022.2039955 |
Ejemplares similares
-
Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case–control study protocol
por: Szakács, Zsolt, et al.
Publicado: (2019) -
Cross-sectional study of coeliac autoimmunity in a population of Vietnamese children
por: Zanella, Sara, et al.
Publicado: (2016) -
Accuracy of potential diagnostic indicators for coeliac disease: a systematic review protocol
por: Elwenspoek, Martha Maria Christine, et al.
Publicado: (2020) -
The possible link between coeliac and Kawasaki diseases in Brazil: a cross-sectional study
por: dos Santos Domingues, Alessandra, et al.
Publicado: (2018) -
Cardiovascular risk factors in coeliac disease (ARCTIC): a protocol of multicentre series of studies
por: Vereczkei, Zsófia, et al.
Publicado: (2023)